Insights

Loading spinner
Gathering insights about Umoja Biopharma

Umoja Biopharma Tech Stack

Media & News

Umoja Biopharma's Email Address Formats

Umoja Biopharma uses at least 1 format(s):
Umoja Biopharma Email FormatsExamplePercentage
First.Last@umoja-biopharma.comJohn.Doe@umoja-biopharma.com
93%
Last@umoja-biopharma.comDoe@umoja-biopharma.com
5%
FirstMiddle.Last@umoja-biopharma.comJohnMichael.Doe@umoja-biopharma.com
1%
FirLast@umoja-biopharma.comJohDoe@umoja-biopharma.com
1%

Frequently Asked Questions

Where is Umoja Biopharma's headquarters located?

Minus sign iconPlus sign icon
Umoja Biopharma's main headquarters is located at 1150 Eastlake Avenue East, Suite 400. The company has employees across 2 continents, including North AmericaAfrica.

What is Umoja Biopharma's SIC code NAICS code?

Minus sign iconPlus sign icon
Umoja Biopharma's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Umoja Biopharma have currently?

Minus sign iconPlus sign icon
As of January 2026, Umoja Biopharma has approximately 216 employees across 2 continents, including North AmericaAfrica. Key team members include Chief Executive Officer: A. S.Vice President Analytical Development: T. K.Head Of Quality: C. L.. Explore Umoja Biopharma's employee directory with LeadIQ.

What industry does Umoja Biopharma belong to?

Minus sign iconPlus sign icon
Umoja Biopharma operates in the Biotechnology Research industry.

What is Umoja Biopharma's email format?

Minus sign iconPlus sign icon
Umoja Biopharma's email format typically follows the pattern of First.Last@umoja-biopharma.com. Find more Umoja Biopharma email formats with LeadIQ.

How much funding has Umoja Biopharma raised to date?

Minus sign iconPlus sign icon
As of January 2026, Umoja Biopharma has raised $100M in funding. The last funding round occurred on Jan 14, 2025 for $100M.

When was Umoja Biopharma founded?

Minus sign iconPlus sign icon
Umoja Biopharma was founded in 2019.

Umoja Biopharma

Biotechnology ResearchWashington, United States201-500 Employees

Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer. We envision a world where all patients have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies.

Section iconCompany Overview

Headquarters
1150 Eastlake Avenue East, Suite 400
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $100M

    Umoja Biopharma has raised a total of $100M of funding over 4 rounds. Their latest funding round was raised on Jan 14, 2025 in the amount of $100M.

  • $100M$250M

    Umoja Biopharma's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M

    Umoja Biopharma has raised a total of $100M of funding over 4 rounds. Their latest funding round was raised on Jan 14, 2025 in the amount of $100M.

  • $100M$250M

    Umoja Biopharma's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.